Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable enzyme binding activity; ferrous iron binding activity; and hypoxia-inducible factor-proline dioxygenase activity. Involved in several processes, including positive regulation of transcription by RNA polymerase II; regulation of modification of postsynaptic structure; and regulation protein catabolic process at postsynapse. Acts upstream of or within heart morphogenesis and labyrinthine layer development. Is active in glutamatergic synapse and postsynaptic density. Is expressed in central nervous system; genitourinary system; and trunk. Human ortholog(s) of this gene implicated in familial erythrocytosis 3; polycythemia; and renal cell carcinoma. Orthologous to human EGLN1 (egl-9 family hypoxia inducible factor 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.